scholarly journals Dangerous bacteria in unexpected locations; Burkholderia pseudomallei and melioidosis in Australia

2009 ◽  
Vol 30 (5) ◽  
pp. 195
Author(s):  
Bart J Currie

There are 25-50 human cases of melioidosis annually in Australia. While the vast majority occur in the tropical north, sporadic cases have been documented from unexpected temperate locations and, each year, several cases are diagnosed in southern hospitals in patients infected in and returned or travelling from northern Australia or southeast Asia.

2015 ◽  
Vol 144 (6) ◽  
pp. 1330-1337 ◽  
Author(s):  
B. MELOT ◽  
J. COLOT ◽  
F. LACASSIN ◽  
S. TARDIEU ◽  
E. LAPISARDI ◽  
...  

SUMMARYMelioidosis is an infectious disease caused byBurkholderia pseudomallei, a bacterium endemic in Southeast Asia and northern Australia. In New Caledonia, sporadic cases were first described in 2005; since then, more cases have been identified. To improve our understanding of melioidosis epidemiology in New Caledonia, we compared the local cases andB. pseudomalleiisolates with those from endemic areas. Nineteen melioidosis cases have been diagnosed in New Caledonia since 1999, mostly severe and with frequent bacteraemia, leading to three (16%) fatalities. All but one occurred in the North Province. Besides sporadic cases caused by non-clonal strains, we also identified a hotspot of transmission related to a clonal group ofB. pseudomalleithat is phylogenetically related to Australian strains.


2004 ◽  
Vol 48 (5) ◽  
pp. 1763-1765 ◽  
Author(s):  
Allen C. Cheng ◽  
Dale A. Fisher ◽  
Nicholas M. Anstey ◽  
Dianne P. Stephens ◽  
Susan P. Jacups ◽  
...  

ABSTRACT Melioidosis, an infection due to Burkholderia pseudomallei, is endemic in southeast Asia and northern Australia. We reviewed our experience with meropenem in the treatment of severe melioidosis in 63 patients over a 6-year period. Outcomes were similar to those of ceftazidime-treated patients (n = 153) despite a deliberate selection bias to more-unwell patients receiving meropenem. The mortality among meropenem-treated patients was 19%. One patient had a possible drug fever associated with the use of meropenem. We conclude that meropenem (1 g or 25 mg/kg every 8 h intravenously for ≥14 days) is an alternative to ceftazidime and imipenem in the treatment of melioidosis. The use of meropenem may be associated with improved outcomes in patients with severe sepsis associated with melioidosis.


2008 ◽  
Vol 15 (5) ◽  
pp. 237-239 ◽  
Author(s):  
Dimas Mateos Corral ◽  
Allan L Coates ◽  
Yvonne CW Yau ◽  
Raymond Tellier ◽  
Mindy Glass ◽  
...  

Burkholderia pseudomalleiis a pathogen identified with increasing frequency in the respiratory tracts of cystic fibrosis (CF) patients from endemic areas such as Southeast Asia and northern Australia. The following report describes the first known reported case in a CF patient from the Caribbean attending a North American CF clinic.


2019 ◽  
Vol 12 (5) ◽  
pp. e228856 ◽  
Author(s):  
Clément Auvens ◽  
Catherine Neuwirth ◽  
Lionel Piroth ◽  
Mathieu Blot

Melioidosis is a protean disease which is endemic to Southeast Asia and northern Australia. Here, we report a case of infected aortic aneurysm due to Burkholderia pseudomallei in an immunocompetent man 6 months after a trip to northern Malaysia. This patient initially received inappropriate surgical and antibiotic treatment, leading to a peri-prosthetic aortic infection with lumbar spondylitis and contiguous psoas muscle abscess. This case highlights the difficulty of diagnosing melioidosis given its diverse clinical manifestations and the limits of routine microbiological methods to identify B. pseudomallei. Melioidosis should be considered a possible diagnosis in individuals with unexplained fever subsequent to travel in an endemic area.


Author(s):  
Irina B. Zakharova

Introduction. Melioidosis is a severe infection disease with the high mortality rate due to saprophytic bacterium Burkholderia pseudomallei. For the time present, the area of the distribution of the pathogen is much wider than in the case of the traditionally endemic Southeast Asia and Northern Australia and covers the humid tropics and subtropics of all continents. Methods. The search for data and analysis of disease cases in non-endemic areas for the period from 2003 to April 2017. Results. Over the past 15 years, 120 cases of melioidosis in non-endemic countries were described, that is 5,5 times higher than in the same previous period. There is no direct dependence of infection probability on the age and risk factors, but the presence of diabetes or chronic diseases doubles the risk of a fatal outcome of melioidosis. Southeast Asia still prevails as the origin of infection (62.5% of cases), however, the number of imported cases of melioidosis from Mexico, the Caribbean, South America, East Africa, Madagascar, China and the Pacific region begins to increase.


2019 ◽  
Vol 18 (2) ◽  
pp. 64-68
Author(s):  
Raina Chaudhary ◽  
Alina Singh ◽  
Manoj Pradhan ◽  
Reeba Karki ◽  
Paawan Bahadur Bhandari

  Introduction: Melioidosis is potentially fatal type of infectious disease caused by soil saprophytes Burkholderia pseudomallei. It is endemic to Southeast Asia and Northern Australia. We report the case of Cerebral Melioidosis which was consequences of acute otitis media. Patient was treated with Ceftazidime and Meropenem, despite of that patient died. To the best of our knowledge, this is the first case of cerebral melioidosis from Nepal.    


mBio ◽  
2014 ◽  
Vol 5 (2) ◽  
Author(s):  
James A. St. John ◽  
Jenny A. K. Ekberg ◽  
Samantha J. Dando ◽  
Adrian C. B. Meedeniya ◽  
Rachel E. Horton ◽  
...  

ABSTRACT Melioidosis is a potentially fatal disease that is endemic to tropical northern Australia and Southeast Asia, with a mortality rate of 14 to 50%. The bacterium Burkholderia pseudomallei is the causative agent which infects numerous parts of the human body, including the brain, which results in the neurological manifestation of melioidosis. The olfactory nerve constitutes a direct conduit from the nasal cavity into the brain, and we have previously reported that B. pseudomallei can colonize this nerve in mice. We have now investigated in detail the mechanism by which the bacteria penetrate the olfactory and trigeminal nerves within the nasal cavity and infect the brain. We found that the olfactory epithelium responded to intranasal B. pseudomallei infection by widespread crenellation followed by disintegration of the neuronal layer to expose the underlying basal layer, which the bacteria then colonized. With the loss of the neuronal cell bodies, olfactory axons also degenerated, and the bacteria then migrated through the now-open conduit of the olfactory nerves. Using immunohistochemistry, we demonstrated that B. pseudomallei migrated through the cribriform plate via the olfactory nerves to enter the outer layer of the olfactory bulb in the brain within 24 h. We also found that the bacteria colonized the thin respiratory epithelium in the nasal cavity and then rapidly migrated along the underlying trigeminal nerve to penetrate the cranial cavity. These results demonstrate that B. pseudomallei invasion of the nerves of the nasal cavity leads to direct infection of the brain and bypasses the blood-brain barrier. IMPORTANCE Melioidosis is a potentially fatal tropical disease that is endemic to northern Australia and Southeast Asia. It is caused by the bacterium Burkholderia pseudomallei, which can infect many organs of the body, including the brain, and results in neurological symptoms. The pathway by which the bacteria can penetrate the brain is unknown, and we have investigated the ability of the bacteria to migrate along nerves that innervate the nasal cavity and enter the frontal region of the brain by using a mouse model of infection. By generating a mutant strain of B. pseudomallei which is unable to survive in the blood, we show that the bacteria rapidly penetrate the cranial cavity using the olfactory (smell) nerve and the trigeminal (sensory) nerve that line the nasal cavity.


2012 ◽  
Vol 194 (23) ◽  
pp. 6604-6605 ◽  
Author(s):  
Yao Fang ◽  
Yong Huang ◽  
Qian Li ◽  
Hai Chen ◽  
Zhen Yao ◽  
...  

ABSTRACTMelioidosis, caused byBurkholderia pseudomallei, is considered to be endemic to Northern Australia and Southeast Asia, with high mortality and relapse rates, regardless of powerful antibiotic therapy. Here we report the first genome sequence ofBurkholderia pseudomalleistrain BPC006, obtained from a melioidosis patient in Hainan, China. The genome sizes of the 2 chromosomes were determined to be 4,001,777 bp and 3,153,284 bp.


Author(s):  
Irina B. Zakharova

Introduction. Melioidosis is a severe infection disease with the high mortality rate due to saprophytic bacterium Burkholderia pseudomallei. For the time present, the area of the distribution of the pathogen is much wider than in the case of the traditionally endemic Southeast Asia and Northern Australia and covers the humid tropics and subtropics of all continents. Methods. The search for data and analysis of disease cases in non-endemic areas for the period from 2003 to April 2017. Results. Over the past 15 years, 120 cases of melioidosis in non-endemic countries were described, that is 5,5 times higher than in the same previous period. There is no direct dependence of infection probability on the age and risk factors, but the presence of diabetes or chronic diseases doubles the risk of a fatal outcome of melioidosis. Southeast Asia still prevails as the origin of infection (62.5% of cases), however, the number of imported cases of melioidosis from Mexico, the Caribbean, South America, East Africa, Madagascar, China and the Pacific region begins to increase.


2003 ◽  
Vol 117 (5) ◽  
pp. 417-418 ◽  
Author(s):  
Somchai Srirompotong ◽  
Wisoot Reechaipichitkul

Melioidosis is an infectious disease caused by a saprophytic bacterium, Burkholderia pseudomallei. It is endemic to Southeast Asia and Northern Australia. The spectrum of melioidosis in humans varies from sub-clinical to overwhelming protean manifestations resembling other acute and chronic bacterial infections. Disseminated septicaemia melioidosis presenting as a masticator space infection is reported here. This is germane to those treating diabetic patients with deep neck infections living in, or having visited, areas endemic for B. pseudomallei.


Sign in / Sign up

Export Citation Format

Share Document